+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alexion Pharmaceuticals - logo

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

From
DNA-Encoded Libraries: Platforms and Services Market - Product Thumbnail Image

DNA-Encoded Libraries: Platforms and Services Market

  • Report
  • January 2019
  • 133 Pages
  • Global
From
From
From
From
From
From
From
From
Orphan Drugs Global Market Report 2024 - Product Thumbnail Image

Orphan Drugs Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Drug Formulation Global Market Report 2024 - Product Thumbnail Image

Drug Formulation Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Wilson Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Wilson Disease - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 60 Pages
  • Global
From
Guillain-Barre Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Guillain-Barre Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Generalized Myasthenia Gravis (gMG) - Pipeline Insight, 2024 - Product Thumbnail Image

Generalized Myasthenia Gravis (gMG) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Danicopan Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Danicopan Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
Loading Indicator